US 6500839
CRF receptor antagonists and methods relating thereto
expired A61PA61P1/00A61P25/00
Quick answer
US patent 6500839 (CRF receptor antagonists and methods relating thereto) held by Neurocrine Biosciences, Inc. expires Mon Dec 26 2022 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- Neurocrine Biosciences, Inc.
- Grant date
- Tue Dec 31 2002 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 26 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 23
- CPC classes
- A61P, A61P1/00, A61P25/00, A61P25/04, A61P25/10